Fundraising Fox
/People
Sign in

Bennett Smith

SVP, Commercial at Beren

Greater Boston

Find your path to Bennett

240 people in our graph can introduce you to Bennett.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Bobby Gaspar to introduce you to Bennett

You →Bobby · together at Orchard Therapeutics (2023–2025) →Bennett

Ask Jamie Chen to introduce you to Bennett

You →Jamie · 2 people · together at Orchard Therapeutics →Bennett

Ask Sam Okafor to introduce you to Bennett

You →Sam · 9 people · together at Allergan →Bennett

Sign up to find every way you can get introduced to Bennett

  • Your email: the people you already email who know Bennett
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Bennett
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Bennett Smith is SVP, Commercial at Beren Therapeutics, where he leads commercialization efforts toward a planned U.S. launch in 2026 and subsequent global expansion, overseeing the integrated launch plan and building out a VP-level leadership team across marketing, market access, commercial operations, and sales. Over roughly 20 years in pharma and biotech, he has worked on market access, patient services, marketing, and sales initiatives, including the U.S. launch of Victoza® at Novo Nordisk, revenue growth for AURYXIA at Akebia, and access improvements for PRALUENT® at Regeneron. His areas of focus include commercial strategy, rare disease launches, market access, patient services, and P&L ownership.

SVP, Commercial at Beren

Intro paths

→

In turn, Bennett can intro founders to Beren's investors below.

Beren's investors · 5

Alpha Wave GlobalMiamiEisai Innovation, Inc.Cambridge · $5M checksNarya CapitalColumbusOctave Ventures LlcHendersonUTokyo Innovation Platform Co. Ltd.Tokyo

Co-founders at Beren

JCJason Camm
Jason CammFounder, President & Chief Executive Officer

Experience

  1. Beren TherapeuticsSVP, Commercialcurrent2025 — presentGreater Boston
  2. Orchard TherapeuticsSVP, General Manager, North America2023 — 2025Boston, Massachusetts, United States
  3. Akebia TherapeuticsSVP, Commercial2022 — 2023Cambridge, Massachusetts, United States
  4. Akebia TherapeuticsSVP Marketing, Market Access, and Patient Services2021 — 2022
  5. Akebia TherapeuticsVP Market Access and Patient Services2020 — 2021
  6. Akebia TherapeuticsHead, Market Access2019 — 2020Cambridge, MA
  7. Akebia TherapeuticsSr. Director, Market Access2018 — 2020Cambridge, Massachusetts
  8. Regeneron Pharmaceuticals, Inc.Senior Director, Global Market Access2018Tarrytown, NY
  9. Regeneron Pharmaceuticals, Inc.Director, Global Market Access2016 — 2018Tarrytown, NY
  10. Novo NordiskBrand Director, Managed Markets2013 — 2016Plainsboro, NJ
  11. Novo NordiskAssociate Director, Managed Markets2012 — 2013Princeton, NJ
  12. Novo NordiskSr. Manager, Customer Channel Marketing2011 — 2012Princeton, NJ
  13. CrossFit, LLCOwner2010 — 2016Hoboken, NJ
  14. AllerganSegment Marketing Manager2009 — 2011Greater New York City Area
  15. AllerganDivisional Sales Manager2007 — 2009Portland, Oregon Area
  16. AllerganRegional Sales Trainer2006 — 2007Portland, Oregon Area
  17. AllerganHospital Sales Representative2004 — 2006Seattle, WA
  18. AllerganTerritory Sales Representative & Field Trainer2002 — 2004Seattle, WA
  19. ProvizioMarket Analyst2001 — 2002Boise, Idaho Area
  20. J.R. Simplot CompanyMicrobiology Lab Technician2000 — 2001Caldwell, ID

Skills & more

Product Launch Planning1Healthcare Reimbursement1Medicare/Medicaid Reimbursement1Real World Evidence (RWE)payer engagementPricing StrategyCompetitive Intelligenceevidence generationProduct Lifecycle ManagementStakeholder Managementportfolio strategyasset valuation
+12 moreBusiness Model InnovationDue DiligenceCommercializationBiotechnologyCommercialKOLField CoordinationMarket PlanningMarketing StrategyExecutive LeadershipDefining RequirementsStrategy

Languages Armenian · English · Spanish

From Bennett's professional profile.

Frequently asked questions

Who is Bennett Smith?
Bennett Smith is SVP, Commercial at Beren Therapeutics, where he leads commercialization efforts toward a planned U.S. launch in 2026 and subsequent global expansion, overseeing the integrated launch plan and building out a VP-level leadership team across marketing, market access, commercial operations, and sales. Over roughly 20 years in pharma and biotech, he has worked on market access, patient services, marketing, and sales initiatives, including the U.S. launch of Victoza® at Novo Nordisk, revenue growth for AURYXIA at Akebia, and access improvements for PRALUENT® at Regeneron. His areas of focus include commercial strategy, rare disease launches, market access, patient services, and P&L ownership.
Where does Bennett Smith work?
Bennett Smith is SVP, Commercial at Beren.
Where did Bennett Smith go to school?
Bennett Smith studied at University of Washington (Master of Business Administration - MBA, Business Finance and Economics); The College of Idaho (Bachelor of Science - BS, Biology); Eastside Catholic School (High School Diploma, High School/Secondary Diploma Programs).

Same school

Shared employers